Will This Trend Cost Biotech Stock Investors Lots of Money? - Madison.com

money - Google News | October 30, 2016 at 05:09PM | Will This Trend Cost Biotech Stock Investors Lots of Money? - Madison.com

Madison.com

Will This Trend Cost Biotech Stock Investors Lots of Money? Madison.com If real-world results don't match up to clinical study results, then the new pricing model will cause Regeneron, Sanofi, and Amgen to make less money on their cholesterol drugs than they would have under a traditional pricing model. The companies are ... and more »

October 30, 2016 at 05:09PM | money - Google News
Will This Trend Cost Biotech Stock Investors Lots of Money? - Madison.com
money - Google News

money - Google News | October 30, 2016 at 05:09PM | Will This Trend Cost Biotech Stock Investors Lots of Money? - Madison.com